nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—CYP2D6—Pyrimethamine—malaria	0.117	0.229	CbGbCtD
L-DOPA—CYP2D6—Artemether—malaria	0.0995	0.194	CbGbCtD
L-DOPA—CYP2D6—Proguanil—malaria	0.0936	0.183	CbGbCtD
L-DOPA—CYP2D6—Quinidine barbiturate—malaria	0.0887	0.173	CbGbCtD
L-DOPA—CYP2D6—Quinine—malaria	0.0603	0.118	CbGbCtD
L-DOPA—CYP2D6—Quinidine—malaria	0.053	0.103	CbGbCtD
L-DOPA—DDC—blood plasma—malaria	0.00988	0.0743	CbGeAlD
L-DOPA—PSIP1—hematopoietic system—malaria	0.00958	0.0721	CbGeAlD
L-DOPA—PSIP1—digestive system—malaria	0.00667	0.0501	CbGeAlD
L-DOPA—PSIP1—blood—malaria	0.00635	0.0477	CbGeAlD
L-DOPA—PSIP1—bone marrow—malaria	0.00614	0.0462	CbGeAlD
L-DOPA—DRD5—hematopoietic system—malaria	0.00526	0.0395	CbGeAlD
L-DOPA—SLC7A8—kidney—malaria	0.00518	0.0389	CbGeAlD
L-DOPA—SLC7A5—saliva-secreting gland—malaria	0.00513	0.0386	CbGeAlD
L-DOPA—PSIP1—liver—malaria	0.00497	0.0373	CbGeAlD
L-DOPA—SLC7A5—hematopoietic system—malaria	0.0049	0.0368	CbGeAlD
L-DOPA—DDC—kidney—malaria	0.00448	0.0337	CbGeAlD
L-DOPA—PSIP1—brain—malaria	0.00394	0.0296	CbGeAlD
L-DOPA—SLC16A10—hematopoietic system—malaria	0.00375	0.0282	CbGeAlD
L-DOPA—SLC7A5—digestive system—malaria	0.0034	0.0256	CbGeAlD
L-DOPA—SLC15A1—kidney—malaria	0.00333	0.025	CbGeAlD
L-DOPA—DRD4—brain—malaria	0.00328	0.0247	CbGeAlD
L-DOPA—SLC7A8—liver—malaria	0.00327	0.0246	CbGeAlD
L-DOPA—SLC7A5—blood—malaria	0.00324	0.0244	CbGeAlD
L-DOPA—SLC7A5—bone marrow—malaria	0.00314	0.0236	CbGeAlD
L-DOPA—DDC—liver—malaria	0.00283	0.0213	CbGeAlD
L-DOPA—SLC15A1—digestive system—malaria	0.00283	0.0212	CbGeAlD
L-DOPA—SLC7A8—brain—malaria	0.0026	0.0195	CbGeAlD
L-DOPA—CYP2D6—blood plasma—malaria	0.00258	0.0194	CbGeAlD
L-DOPA—SLC7A5—liver—malaria	0.00254	0.0191	CbGeAlD
L-DOPA—SLC16A10—blood—malaria	0.00248	0.0187	CbGeAlD
L-DOPA—DRD3—brain—malaria	0.00231	0.0173	CbGeAlD
L-DOPA—DDC—brain—malaria	0.00225	0.0169	CbGeAlD
L-DOPA—DRD5—brain—malaria	0.00216	0.0162	CbGeAlD
L-DOPA—SLC15A1—liver—malaria	0.00211	0.0158	CbGeAlD
L-DOPA—SLC7A5—brain—malaria	0.00201	0.0151	CbGeAlD
L-DOPA—SLC16A10—liver—malaria	0.00194	0.0146	CbGeAlD
L-DOPA—DRD1—brain—malaria	0.00165	0.0124	CbGeAlD
L-DOPA—CYP2D6—hematopoietic system—malaria	0.00143	0.0107	CbGeAlD
L-DOPA—Abdominal pain—Proguanil—malaria	0.00125	0.00364	CcSEcCtD
L-DOPA—Neuropathy peripheral—Dapsone—malaria	0.00125	0.00361	CcSEcCtD
L-DOPA—Urinary tract infection—Clindamycin—malaria	0.00119	0.00347	CcSEcCtD
L-DOPA—Angina pectoris—Quinidine barbiturate—malaria	0.00119	0.00345	CcSEcCtD
L-DOPA—Angina pectoris—Pentoxifylline—malaria	0.00119	0.00344	CcSEcCtD
L-DOPA—CYP2D6—kidney—malaria	0.00117	0.00879	CbGeAlD
L-DOPA—Leukopenia—Sulfadiazine—malaria	0.00115	0.00335	CcSEcCtD
L-DOPA—Agranulocytosis—Clindamycin—malaria	0.00115	0.00333	CcSEcCtD
L-DOPA—Agranulocytosis—Quinidine—malaria	0.00113	0.00327	CcSEcCtD
L-DOPA—Agranulocytosis—Quinine—malaria	0.00113	0.00327	CcSEcCtD
L-DOPA—Convulsion—Sulfadiazine—malaria	0.00112	0.00324	CcSEcCtD
L-DOPA—Haemoglobin—Quinidine—malaria	0.00109	0.00316	CcSEcCtD
L-DOPA—Haemoglobin—Quinine—malaria	0.00109	0.00316	CcSEcCtD
L-DOPA—Diarrhoea—Proguanil—malaria	0.00108	0.00315	CcSEcCtD
L-DOPA—Haemorrhage—Quinidine—malaria	0.00108	0.00314	CcSEcCtD
L-DOPA—Haemorrhage—Quinine—malaria	0.00108	0.00314	CcSEcCtD
L-DOPA—Urinary tract disorder—Quinidine—malaria	0.00107	0.0031	CcSEcCtD
L-DOPA—Urinary tract disorder—Quinine—malaria	0.00107	0.0031	CcSEcCtD
L-DOPA—Urethral disorder—Quinidine—malaria	0.00106	0.00308	CcSEcCtD
L-DOPA—Urethral disorder—Quinine—malaria	0.00106	0.00308	CcSEcCtD
L-DOPA—Thrombocytopenia—Sulfadiazine—malaria	0.00103	0.00299	CcSEcCtD
L-DOPA—Flushing—Clindamycin—malaria	0.00102	0.00297	CcSEcCtD
L-DOPA—Agranulocytosis—Quinidine barbiturate—malaria	0.00102	0.00295	CcSEcCtD
L-DOPA—Vomiting—Proguanil—malaria	0.00101	0.00293	CcSEcCtD
L-DOPA—Flushing—Quinidine—malaria	0.001	0.00292	CcSEcCtD
L-DOPA—Flushing—Quinine—malaria	0.001	0.00292	CcSEcCtD
L-DOPA—Anorexia—Sulfadiazine—malaria	0.001	0.00291	CcSEcCtD
L-DOPA—Rash—Proguanil—malaria	0.001	0.0029	CcSEcCtD
L-DOPA—Dermatitis—Proguanil—malaria	0.000999	0.0029	CcSEcCtD
L-DOPA—PSIP1—Early Phase of HIV Life Cycle—CD4—malaria	0.000995	0.096	CbGpPWpGaD
L-DOPA—Headache—Proguanil—malaria	0.000993	0.00288	CcSEcCtD
L-DOPA—CYP2D6—digestive system—malaria	0.000991	0.00745	CbGeAlD
L-DOPA—Haemoglobin—Quinidine barbiturate—malaria	0.000982	0.00285	CcSEcCtD
L-DOPA—Haemoglobin—Pentoxifylline—malaria	0.00098	0.00284	CcSEcCtD
L-DOPA—Haemorrhage—Quinidine barbiturate—malaria	0.000977	0.00283	CcSEcCtD
L-DOPA—DRD2—brain—malaria	0.000975	0.00733	CbGeAlD
L-DOPA—Haemorrhage—Pentoxifylline—malaria	0.000975	0.00283	CcSEcCtD
L-DOPA—Hallucination—Quinidine barbiturate—malaria	0.000972	0.00282	CcSEcCtD
L-DOPA—Urinary tract disorder—Quinidine barbiturate—malaria	0.000965	0.0028	CcSEcCtD
L-DOPA—Urethral disorder—Quinidine barbiturate—malaria	0.000957	0.00278	CcSEcCtD
L-DOPA—Insomnia—Sulfadiazine—malaria	0.000952	0.00276	CcSEcCtD
L-DOPA—Mental disorder—Quinidine—malaria	0.000948	0.00275	CcSEcCtD
L-DOPA—Mental disorder—Quinine—malaria	0.000948	0.00275	CcSEcCtD
L-DOPA—Flatulence—Clindamycin—malaria	0.000946	0.00275	CcSEcCtD
L-DOPA—CYP2D6—blood—malaria	0.000945	0.0071	CbGeAlD
L-DOPA—Nausea—Proguanil—malaria	0.000942	0.00273	CcSEcCtD
L-DOPA—Dysgeusia—Clindamycin—malaria	0.00094	0.00273	CcSEcCtD
L-DOPA—Vision blurred—Dapsone—malaria	0.000936	0.00272	CcSEcCtD
L-DOPA—Back pain—Clindamycin—malaria	0.000929	0.0027	CcSEcCtD
L-DOPA—Muscle spasms—Clindamycin—malaria	0.000923	0.00268	CcSEcCtD
L-DOPA—Decreased appetite—Sulfadiazine—malaria	0.000915	0.00266	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Sulfadiazine—malaria	0.000909	0.00264	CcSEcCtD
L-DOPA—Flushing—Quinidine barbiturate—malaria	0.000907	0.00263	CcSEcCtD
L-DOPA—Flushing—Pentoxifylline—malaria	0.000905	0.00263	CcSEcCtD
L-DOPA—Vision blurred—Quinidine—malaria	0.000888	0.00258	CcSEcCtD
L-DOPA—Vision blurred—Quinine—malaria	0.000888	0.00258	CcSEcCtD
L-DOPA—Anaemia—Clindamycin—malaria	0.000888	0.00258	CcSEcCtD
L-DOPA—Tremor—Quinidine—malaria	0.000883	0.00256	CcSEcCtD
L-DOPA—Tremor—Quinine—malaria	0.000883	0.00256	CcSEcCtD
L-DOPA—Arrhythmia—Pentoxifylline—malaria	0.000871	0.00253	CcSEcCtD
L-DOPA—Cough—Dapsone—malaria	0.000866	0.00251	CcSEcCtD
L-DOPA—Agitation—Quinidine—malaria	0.000866	0.00251	CcSEcCtD
L-DOPA—Agitation—Quinine—malaria	0.000866	0.00251	CcSEcCtD
L-DOPA—Angioedema—Quinine—malaria	0.000861	0.0025	CcSEcCtD
L-DOPA—Angioedema—Quinidine—malaria	0.000861	0.0025	CcSEcCtD
L-DOPA—Gastrointestinal pain—Sulfadiazine—malaria	0.000861	0.0025	CcSEcCtD
L-DOPA—Leukopenia—Clindamycin—malaria	0.00086	0.00249	CcSEcCtD
L-DOPA—Mental disorder—Quinidine barbiturate—malaria	0.000856	0.00248	CcSEcCtD
L-DOPA—Syncope—Quinidine—malaria	0.000845	0.00245	CcSEcCtD
L-DOPA—Syncope—Quinine—malaria	0.000845	0.00245	CcSEcCtD
L-DOPA—Leukopenia—Quinidine—malaria	0.000843	0.00245	CcSEcCtD
L-DOPA—Leukopenia—Quinine—malaria	0.000843	0.00245	CcSEcCtD
L-DOPA—Flatulence—Pentoxifylline—malaria	0.000836	0.00243	CcSEcCtD
L-DOPA—Urticaria—Sulfadiazine—malaria	0.000836	0.00243	CcSEcCtD
L-DOPA—Tension—Quinidine barbiturate—malaria	0.000834	0.00242	CcSEcCtD
L-DOPA—Tension—Pentoxifylline—malaria	0.000833	0.00242	CcSEcCtD
L-DOPA—Palpitations—Quinidine—malaria	0.000833	0.00242	CcSEcCtD
L-DOPA—Palpitations—Quinine—malaria	0.000833	0.00242	CcSEcCtD
L-DOPA—Abdominal pain—Sulfadiazine—malaria	0.000832	0.00241	CcSEcCtD
L-DOPA—Dysgeusia—Pentoxifylline—malaria	0.000831	0.00241	CcSEcCtD
L-DOPA—Hypertension—Clindamycin—malaria	0.000829	0.00241	CcSEcCtD
L-DOPA—Loss of consciousness—Quinidine—malaria	0.000828	0.0024	CcSEcCtD
L-DOPA—Loss of consciousness—Quinine—malaria	0.000828	0.0024	CcSEcCtD
L-DOPA—Nervousness—Quinidine barbiturate—malaria	0.000826	0.0024	CcSEcCtD
L-DOPA—Nervousness—Pentoxifylline—malaria	0.000824	0.00239	CcSEcCtD
L-DOPA—Back pain—Pentoxifylline—malaria	0.000821	0.00238	CcSEcCtD
L-DOPA—Convulsion—Quinidine—malaria	0.000816	0.00237	CcSEcCtD
L-DOPA—Convulsion—Quinine—malaria	0.000816	0.00237	CcSEcCtD
L-DOPA—Muscle spasms—Pentoxifylline—malaria	0.000816	0.00237	CcSEcCtD
L-DOPA—Discomfort—Clindamycin—malaria	0.000808	0.00234	CcSEcCtD
L-DOPA—Chest pain—Quinine—malaria	0.000802	0.00233	CcSEcCtD
L-DOPA—Chest pain—Quinidine—malaria	0.000802	0.00233	CcSEcCtD
L-DOPA—Vision blurred—Quinidine barbiturate—malaria	0.000801	0.00233	CcSEcCtD
L-DOPA—Vision blurred—Pentoxifylline—malaria	0.0008	0.00232	CcSEcCtD
L-DOPA—Tremor—Quinidine barbiturate—malaria	0.000797	0.00231	CcSEcCtD
L-DOPA—Tremor—Pentoxifylline—malaria	0.000795	0.00231	CcSEcCtD
L-DOPA—Ill-defined disorder—Pentoxifylline—malaria	0.000787	0.00229	CcSEcCtD
L-DOPA—Anaemia—Pentoxifylline—malaria	0.000784	0.00228	CcSEcCtD
L-DOPA—Agitation—Quinidine barbiturate—malaria	0.000781	0.00227	CcSEcCtD
L-DOPA—Agitation—Pentoxifylline—malaria	0.00078	0.00226	CcSEcCtD
L-DOPA—Angioedema—Quinidine barbiturate—malaria	0.000777	0.00225	CcSEcCtD
L-DOPA—SLC7A8—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.000777	0.0749	CbGpPWpGaD
L-DOPA—Angioedema—Pentoxifylline—malaria	0.000776	0.00225	CcSEcCtD
L-DOPA—Hypersensitivity—Sulfadiazine—malaria	0.000775	0.00225	CcSEcCtD
L-DOPA—Confusional state—Quinine—malaria	0.000775	0.00225	CcSEcCtD
L-DOPA—Confusional state—Quinidine—malaria	0.000775	0.00225	CcSEcCtD
L-DOPA—Oedema—Quinidine—malaria	0.000769	0.00223	CcSEcCtD
L-DOPA—Oedema—Quinine—malaria	0.000769	0.00223	CcSEcCtD
L-DOPA—Thrombocytopenia—Clindamycin—malaria	0.000767	0.00223	CcSEcCtD
L-DOPA—Malaise—Pentoxifylline—malaria	0.000765	0.00222	CcSEcCtD
L-DOPA—Syncope—Quinidine barbiturate—malaria	0.000763	0.00221	CcSEcCtD
L-DOPA—Leukopenia—Quinidine barbiturate—malaria	0.000761	0.00221	CcSEcCtD
L-DOPA—Leukopenia—Pentoxifylline—malaria	0.00076	0.0022	CcSEcCtD
L-DOPA—Shock—Quinine—malaria	0.000756	0.0022	CcSEcCtD
L-DOPA—Shock—Quinidine—malaria	0.000756	0.0022	CcSEcCtD
L-DOPA—Thrombocytopenia—Quinine—malaria	0.000753	0.00218	CcSEcCtD
L-DOPA—Thrombocytopenia—Quinidine—malaria	0.000753	0.00218	CcSEcCtD
L-DOPA—Palpitations—Quinidine barbiturate—malaria	0.000751	0.00218	CcSEcCtD
L-DOPA—Palpitations—Pentoxifylline—malaria	0.00075	0.00218	CcSEcCtD
L-DOPA—Loss of consciousness—Quinidine barbiturate—malaria	0.000747	0.00217	CcSEcCtD
L-DOPA—Pruritus—Sulfadiazine—malaria	0.000745	0.00216	CcSEcCtD
L-DOPA—Hyperhidrosis—Quinidine—malaria	0.000743	0.00216	CcSEcCtD
L-DOPA—Hyperhidrosis—Quinine—malaria	0.000743	0.00216	CcSEcCtD
L-DOPA—CYP2D6—liver—malaria	0.000739	0.00555	CbGeAlD
L-DOPA—Convulsion—Quinidine barbiturate—malaria	0.000737	0.00214	CcSEcCtD
L-DOPA—Convulsion—Pentoxifylline—malaria	0.000735	0.00213	CcSEcCtD
L-DOPA—Anorexia—Quinine—malaria	0.000733	0.00213	CcSEcCtD
L-DOPA—Anorexia—Quinidine—malaria	0.000733	0.00213	CcSEcCtD
L-DOPA—Insomnia—Dapsone—malaria	0.000733	0.00213	CcSEcCtD
L-DOPA—Hypertension—Pentoxifylline—malaria	0.000733	0.00213	CcSEcCtD
L-DOPA—Hypotension—Clindamycin—malaria	0.000732	0.00213	CcSEcCtD
L-DOPA—Chest pain—Quinidine barbiturate—malaria	0.000724	0.0021	CcSEcCtD
L-DOPA—Chest pain—Pentoxifylline—malaria	0.000723	0.0021	CcSEcCtD
L-DOPA—Anxiety—Quinidine barbiturate—malaria	0.000721	0.00209	CcSEcCtD
L-DOPA—Diarrhoea—Sulfadiazine—malaria	0.00072	0.00209	CcSEcCtD
L-DOPA—Anxiety—Pentoxifylline—malaria	0.00072	0.00209	CcSEcCtD
L-DOPA—Hypotension—Quinine—malaria	0.000719	0.00209	CcSEcCtD
L-DOPA—Hypotension—Quinidine—malaria	0.000719	0.00209	CcSEcCtD
L-DOPA—Discomfort—Pentoxifylline—malaria	0.000714	0.00207	CcSEcCtD
L-DOPA—Dry mouth—Pentoxifylline—malaria	0.000707	0.00205	CcSEcCtD
L-DOPA—Confusional state—Quinidine barbiturate—malaria	0.0007	0.00203	CcSEcCtD
L-DOPA—Dyspnoea—Clindamycin—malaria	0.000699	0.00203	CcSEcCtD
L-DOPA—Confusional state—Pentoxifylline—malaria	0.000698	0.00203	CcSEcCtD
L-DOPA—Oedema—Quinidine barbiturate—malaria	0.000694	0.00201	CcSEcCtD
L-DOPA—Oedema—Pentoxifylline—malaria	0.000693	0.00201	CcSEcCtD
L-DOPA—Dyspepsia—Clindamycin—malaria	0.00069	0.002	CcSEcCtD
L-DOPA—Dyspnoea—Quinidine—malaria	0.000686	0.00199	CcSEcCtD
L-DOPA—Dyspnoea—Quinine—malaria	0.000686	0.00199	CcSEcCtD
L-DOPA—Shock—Quinidine barbiturate—malaria	0.000683	0.00198	CcSEcCtD
L-DOPA—Shock—Pentoxifylline—malaria	0.000681	0.00198	CcSEcCtD
L-DOPA—Thrombocytopenia—Quinidine barbiturate—malaria	0.000679	0.00197	CcSEcCtD
L-DOPA—Thrombocytopenia—Pentoxifylline—malaria	0.000678	0.00197	CcSEcCtD
L-DOPA—SLC7A5—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.000678	0.0654	CbGpPWpGaD
L-DOPA—Gastrointestinal disorder—Clindamycin—malaria	0.000677	0.00196	CcSEcCtD
L-DOPA—Fatigue—Clindamycin—malaria	0.000676	0.00196	CcSEcCtD
L-DOPA—Hyperhidrosis—Quinidine barbiturate—malaria	0.000671	0.00195	CcSEcCtD
L-DOPA—Pain—Clindamycin—malaria	0.00067	0.00195	CcSEcCtD
L-DOPA—Constipation—Clindamycin—malaria	0.00067	0.00195	CcSEcCtD
L-DOPA—Hyperhidrosis—Pentoxifylline—malaria	0.00067	0.00194	CcSEcCtD
L-DOPA—Vomiting—Sulfadiazine—malaria	0.000669	0.00194	CcSEcCtD
L-DOPA—Decreased appetite—Quinine—malaria	0.000668	0.00194	CcSEcCtD
L-DOPA—Decreased appetite—Quinidine—malaria	0.000668	0.00194	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Quinidine—malaria	0.000664	0.00193	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Quinine—malaria	0.000664	0.00193	CcSEcCtD
L-DOPA—Rash—Sulfadiazine—malaria	0.000664	0.00193	CcSEcCtD
L-DOPA—Dermatitis—Sulfadiazine—malaria	0.000663	0.00192	CcSEcCtD
L-DOPA—Gastrointestinal pain—Dapsone—malaria	0.000663	0.00192	CcSEcCtD
L-DOPA—Anorexia—Quinidine barbiturate—malaria	0.000661	0.00192	CcSEcCtD
L-DOPA—Anorexia—Pentoxifylline—malaria	0.00066	0.00192	CcSEcCtD
L-DOPA—Headache—Sulfadiazine—malaria	0.000659	0.00191	CcSEcCtD
L-DOPA—Hypotension—Quinidine barbiturate—malaria	0.000648	0.00188	CcSEcCtD
L-DOPA—Hypotension—Pentoxifylline—malaria	0.000647	0.00188	CcSEcCtD
L-DOPA—Gastrointestinal pain—Clindamycin—malaria	0.000641	0.00186	CcSEcCtD
L-DOPA—Abdominal pain—Dapsone—malaria	0.000641	0.00186	CcSEcCtD
L-DOPA—Feeling abnormal—Quinine—malaria	0.000634	0.00184	CcSEcCtD
L-DOPA—Feeling abnormal—Quinidine—malaria	0.000634	0.00184	CcSEcCtD
L-DOPA—Gastrointestinal pain—Quinidine—malaria	0.000629	0.00182	CcSEcCtD
L-DOPA—Gastrointestinal pain—Quinine—malaria	0.000629	0.00182	CcSEcCtD
L-DOPA—Insomnia—Pentoxifylline—malaria	0.000627	0.00182	CcSEcCtD
L-DOPA—Nausea—Sulfadiazine—malaria	0.000625	0.00181	CcSEcCtD
L-DOPA—Urticaria—Clindamycin—malaria	0.000623	0.00181	CcSEcCtD
L-DOPA—Abdominal pain—Clindamycin—malaria	0.00062	0.0018	CcSEcCtD
L-DOPA—Dyspnoea—Quinidine barbiturate—malaria	0.000619	0.0018	CcSEcCtD
L-DOPA—Dyspnoea—Pentoxifylline—malaria	0.000618	0.00179	CcSEcCtD
L-DOPA—Somnolence—Quinidine barbiturate—malaria	0.000617	0.00179	CcSEcCtD
L-DOPA—Somnolence—Pentoxifylline—malaria	0.000616	0.00179	CcSEcCtD
L-DOPA—Urticaria—Quinidine—malaria	0.000611	0.00177	CcSEcCtD
L-DOPA—Urticaria—Quinine—malaria	0.000611	0.00177	CcSEcCtD
L-DOPA—Dyspepsia—Pentoxifylline—malaria	0.00061	0.00177	CcSEcCtD
L-DOPA—Abdominal pain—Quinidine—malaria	0.000608	0.00176	CcSEcCtD
L-DOPA—Abdominal pain—Quinine—malaria	0.000608	0.00176	CcSEcCtD
L-DOPA—Decreased appetite—Quinidine barbiturate—malaria	0.000603	0.00175	CcSEcCtD
L-DOPA—Decreased appetite—Pentoxifylline—malaria	0.000602	0.00175	CcSEcCtD
L-DOPA—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000599	0.00174	CcSEcCtD
L-DOPA—Pain—Quinidine barbiturate—malaria	0.000593	0.00172	CcSEcCtD
L-DOPA—Constipation—Quinidine barbiturate—malaria	0.000593	0.00172	CcSEcCtD
L-DOPA—Constipation—Pentoxifylline—malaria	0.000592	0.00172	CcSEcCtD
L-DOPA—CYP2D6—brain—malaria	0.000586	0.00441	CbGeAlD
L-DOPA—Hypersensitivity—Clindamycin—malaria	0.000577	0.00168	CcSEcCtD
L-DOPA—Feeling abnormal—Quinidine barbiturate—malaria	0.000572	0.00166	CcSEcCtD
L-DOPA—Feeling abnormal—Pentoxifylline—malaria	0.000571	0.00166	CcSEcCtD
L-DOPA—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000567	0.00165	CcSEcCtD
L-DOPA—Hypersensitivity—Quinidine—malaria	0.000567	0.00164	CcSEcCtD
L-DOPA—Hypersensitivity—Quinine—malaria	0.000567	0.00164	CcSEcCtD
L-DOPA—Gastrointestinal pain—Pentoxifylline—malaria	0.000566	0.00164	CcSEcCtD
L-DOPA—Asthenia—Clindamycin—malaria	0.000562	0.00163	CcSEcCtD
L-DOPA—Pruritus—Clindamycin—malaria	0.000555	0.00161	CcSEcCtD
L-DOPA—Asthenia—Quinidine—malaria	0.000552	0.0016	CcSEcCtD
L-DOPA—Asthenia—Quinine—malaria	0.000552	0.0016	CcSEcCtD
L-DOPA—Urticaria—Quinidine barbiturate—malaria	0.000551	0.0016	CcSEcCtD
L-DOPA—Urticaria—Pentoxifylline—malaria	0.00055	0.0016	CcSEcCtD
L-DOPA—Abdominal pain—Quinidine barbiturate—malaria	0.000549	0.00159	CcSEcCtD
L-DOPA—Abdominal pain—Pentoxifylline—malaria	0.000548	0.00159	CcSEcCtD
L-DOPA—Pruritus—Quinidine—malaria	0.000544	0.00158	CcSEcCtD
L-DOPA—Pruritus—Quinine—malaria	0.000544	0.00158	CcSEcCtD
L-DOPA—Diarrhoea—Clindamycin—malaria	0.000536	0.00156	CcSEcCtD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000527	0.0508	CbGpPWpGaD
L-DOPA—Diarrhoea—Quinidine—malaria	0.000526	0.00153	CcSEcCtD
L-DOPA—Diarrhoea—Quinine—malaria	0.000526	0.00153	CcSEcCtD
L-DOPA—Dizziness—Clindamycin—malaria	0.000518	0.0015	CcSEcCtD
L-DOPA—Vomiting—Dapsone—malaria	0.000515	0.0015	CcSEcCtD
L-DOPA—Hypersensitivity—Quinidine barbiturate—malaria	0.000511	0.00148	CcSEcCtD
L-DOPA—Hypersensitivity—Pentoxifylline—malaria	0.00051	0.00148	CcSEcCtD
L-DOPA—Dizziness—Quinine—malaria	0.000508	0.00148	CcSEcCtD
L-DOPA—Dizziness—Quinidine—malaria	0.000508	0.00148	CcSEcCtD
L-DOPA—Headache—Dapsone—malaria	0.000508	0.00147	CcSEcCtD
L-DOPA—Vomiting—Clindamycin—malaria	0.000498	0.00145	CcSEcCtD
L-DOPA—Asthenia—Quinidine barbiturate—malaria	0.000498	0.00144	CcSEcCtD
L-DOPA—Asthenia—Pentoxifylline—malaria	0.000497	0.00144	CcSEcCtD
L-DOPA—Rash—Clindamycin—malaria	0.000494	0.00143	CcSEcCtD
L-DOPA—Dermatitis—Clindamycin—malaria	0.000494	0.00143	CcSEcCtD
L-DOPA—Headache—Clindamycin—malaria	0.000491	0.00143	CcSEcCtD
L-DOPA—Pruritus—Quinidine barbiturate—malaria	0.000491	0.00142	CcSEcCtD
L-DOPA—Pruritus—Pentoxifylline—malaria	0.00049	0.00142	CcSEcCtD
L-DOPA—Vomiting—Quinine—malaria	0.000489	0.00142	CcSEcCtD
L-DOPA—Vomiting—Quinidine—malaria	0.000489	0.00142	CcSEcCtD
L-DOPA—Rash—Quinidine—malaria	0.000485	0.00141	CcSEcCtD
L-DOPA—Rash—Quinine—malaria	0.000485	0.00141	CcSEcCtD
L-DOPA—Dermatitis—Quinine—malaria	0.000484	0.00141	CcSEcCtD
L-DOPA—Dermatitis—Quinidine—malaria	0.000484	0.00141	CcSEcCtD
L-DOPA—Headache—Quinidine—malaria	0.000482	0.0014	CcSEcCtD
L-DOPA—Headache—Quinine—malaria	0.000482	0.0014	CcSEcCtD
L-DOPA—Nausea—Dapsone—malaria	0.000481	0.0014	CcSEcCtD
L-DOPA—Diarrhoea—Quinidine barbiturate—malaria	0.000475	0.00138	CcSEcCtD
L-DOPA—Diarrhoea—Pentoxifylline—malaria	0.000474	0.00138	CcSEcCtD
L-DOPA—Nausea—Clindamycin—malaria	0.000466	0.00135	CcSEcCtD
L-DOPA—Dizziness—Quinidine barbiturate—malaria	0.000459	0.00133	CcSEcCtD
L-DOPA—Dizziness—Pentoxifylline—malaria	0.000458	0.00133	CcSEcCtD
L-DOPA—Nausea—Quinidine—malaria	0.000457	0.00133	CcSEcCtD
L-DOPA—Nausea—Quinine—malaria	0.000457	0.00133	CcSEcCtD
L-DOPA—SLC16A10—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.00045	0.0434	CbGpPWpGaD
L-DOPA—Vomiting—Quinidine barbiturate—malaria	0.000441	0.00128	CcSEcCtD
L-DOPA—Vomiting—Pentoxifylline—malaria	0.00044	0.00128	CcSEcCtD
L-DOPA—Rash—Quinidine barbiturate—malaria	0.000438	0.00127	CcSEcCtD
L-DOPA—Dermatitis—Quinidine barbiturate—malaria	0.000437	0.00127	CcSEcCtD
L-DOPA—Rash—Pentoxifylline—malaria	0.000437	0.00127	CcSEcCtD
L-DOPA—Dermatitis—Pentoxifylline—malaria	0.000436	0.00127	CcSEcCtD
L-DOPA—Headache—Quinidine barbiturate—malaria	0.000435	0.00126	CcSEcCtD
L-DOPA—Headache—Pentoxifylline—malaria	0.000434	0.00126	CcSEcCtD
L-DOPA—Nausea—Quinidine barbiturate—malaria	0.000412	0.0012	CcSEcCtD
L-DOPA—Nausea—Pentoxifylline—malaria	0.000411	0.00119	CcSEcCtD
L-DOPA—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC4A1—malaria	0.00035	0.0337	CbGpPWpGaD
L-DOPA—SLC7A8—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000347	0.0335	CbGpPWpGaD
L-DOPA—SLC7A5—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000303	0.0292	CbGpPWpGaD
L-DOPA—DRD4—GPCRs, Other—ACKR1—malaria	0.000233	0.0224	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.000227	0.0219	CbGpPWpGaD
L-DOPA—DRD3—GPCRs, Other—ACKR1—malaria	0.000207	0.0199	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000202	0.0195	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000201	0.0194	CbGpPWpGaD
L-DOPA—SLC16A10—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000201	0.0194	CbGpPWpGaD
L-DOPA—SLC7A8—Transmembrane transport of small molecules—SLC4A1—malaria	0.000176	0.017	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—HBB—malaria	0.000173	0.0167	CbGpPWpGaD
L-DOPA—PSIP1—Host Interactions of HIV factors—CD4—malaria	0.000172	0.0166	CbGpPWpGaD
L-DOPA—PSIP1—HIV Life Cycle—CD4—malaria	0.000161	0.0156	CbGpPWpGaD
L-DOPA—SLC15A1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000156	0.0151	CbGpPWpGaD
L-DOPA—SLC7A5—Transmembrane transport of small molecules—SLC4A1—malaria	0.000154	0.0148	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—HBB—malaria	0.000151	0.0146	CbGpPWpGaD
L-DOPA—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000147	0.0141	CbGpPWpGaD
L-DOPA—DRD5—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	0.000117	0.0113	CbGpPWpGaD
L-DOPA—PSIP1—Disease—PKLR—malaria	0.000115	0.0111	CbGpPWpGaD
L-DOPA—PSIP1—HIV Infection—CD4—malaria	0.000112	0.0108	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—IL10—malaria	0.000104	0.01	CbGpPWpGaD
L-DOPA—SLC16A10—Transmembrane transport of small molecules—SLC4A1—malaria	0.000102	0.00986	CbGpPWpGaD
L-DOPA—PSIP1—Disease—G6PD—malaria	0.000102	0.00985	CbGpPWpGaD
L-DOPA—DRD5—GPCR ligand binding—ACKR1—malaria	8.93e-05	0.00862	CbGpPWpGaD
L-DOPA—DRD4—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	8.66e-05	0.00835	CbGpPWpGaD
L-DOPA—SLC15A1—Transmembrane transport of small molecules—SLC4A1—malaria	7.94e-05	0.00766	CbGpPWpGaD
L-DOPA—DRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	7.79e-05	0.00752	CbGpPWpGaD
L-DOPA—DRD3—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	7.69e-05	0.00742	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—FAS—malaria	7.59e-05	0.00732	CbGpPWpGaD
L-DOPA—PSIP1—Disease—DHFR—malaria	7.23e-05	0.00697	CbGpPWpGaD
L-DOPA—DRD4—GPCR ligand binding—ACKR1—malaria	6.59e-05	0.00636	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—NOS2—malaria	6.49e-05	0.00626	CbGpPWpGaD
L-DOPA—DDC—Metabolism—DHODH—malaria	6.06e-05	0.00585	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—CD36—malaria	6.05e-05	0.00583	CbGpPWpGaD
L-DOPA—DRD1—GPCR ligand binding—ACKR1—malaria	5.93e-05	0.00573	CbGpPWpGaD
L-DOPA—DRD2—Class A/1 (Rhodopsin-like receptors)—ACKR1—malaria	5.88e-05	0.00568	CbGpPWpGaD
L-DOPA—DRD3—GPCR ligand binding—ACKR1—malaria	5.86e-05	0.00565	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—IL1B—malaria	5.44e-05	0.00525	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—CD36—malaria	5.28e-05	0.00509	CbGpPWpGaD
L-DOPA—DDC—Metabolism—SLC4A1—malaria	5.15e-05	0.00497	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—NOS2—malaria	4.97e-05	0.0048	CbGpPWpGaD
L-DOPA—DDC—Metabolism—DECR1—malaria	4.85e-05	0.00468	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—ACKR1—malaria	4.58e-05	0.00442	CbGpPWpGaD
L-DOPA—DRD2—GPCR ligand binding—ACKR1—malaria	4.48e-05	0.00432	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—FAS—malaria	4.4e-05	0.00425	CbGpPWpGaD
L-DOPA—DDC—Metabolism—HBB—malaria	4.38e-05	0.00423	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—NOS2—malaria	4.34e-05	0.00418	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—FAS—malaria	3.96e-05	0.00382	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—TNF—malaria	3.95e-05	0.00381	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—FAS—malaria	3.91e-05	0.00377	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PKLR—malaria	3.91e-05	0.00377	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—NOS2—malaria	3.77e-05	0.00363	CbGpPWpGaD
L-DOPA—PSIP1—Disease—NOS2—malaria	3.69e-05	0.00356	CbGpPWpGaD
L-DOPA—CYP2D6—Biological oxidations—HPGDS—malaria	3.57e-05	0.00344	CbGpPWpGaD
L-DOPA—DDC—Metabolism—G6PD—malaria	3.48e-05	0.00336	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—NOS2—malaria	3.39e-05	0.00327	CbGpPWpGaD
L-DOPA—SLC7A8—Hemostasis—IL2—malaria	3.39e-05	0.00327	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—ACKR1—malaria	3.38e-05	0.00326	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—NOS2—malaria	3.34e-05	0.00323	CbGpPWpGaD
L-DOPA—DDC—SIDS Susceptibility Pathways—IL6—malaria	3.19e-05	0.00307	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—ACKR1—malaria	3.05e-05	0.00294	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—ACKR1—malaria	3e-05	0.0029	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—FAS—malaria	2.99e-05	0.00289	CbGpPWpGaD
L-DOPA—SLC7A5—Hemostasis—IL2—malaria	2.96e-05	0.00285	CbGpPWpGaD
L-DOPA—PSIP1—Disease—CD4—malaria	2.73e-05	0.00264	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ACKR1—malaria	2.71e-05	0.00261	CbGpPWpGaD
L-DOPA—DDC—Metabolism—HPGDS—malaria	2.66e-05	0.00256	CbGpPWpGaD
L-DOPA—DDC—Circadian rythm related genes—IL6—malaria	2.6e-05	0.00251	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—NOS2—malaria	2.56e-05	0.00247	CbGpPWpGaD
L-DOPA—DDC—Metabolism—DHFR—malaria	2.46e-05	0.00238	CbGpPWpGaD
L-DOPA—DDC—Metabolism—SCARB1—malaria	2.44e-05	0.00235	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ACKR1—malaria	2.3e-05	0.00222	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TLR9—malaria	2.18e-05	0.00211	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ACKR1—malaria	2e-05	0.00193	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ACKR1—malaria	1.8e-05	0.00174	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ACKR1—malaria	1.78e-05	0.00171	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TLR9—malaria	1.61e-05	0.00155	CbGpPWpGaD
L-DOPA—DDC—Metabolism—CD36—malaria	1.53e-05	0.00148	CbGpPWpGaD
L-DOPA—DRD4—Circadian rythm related genes—IL6—malaria	1.51e-05	0.00146	CbGpPWpGaD
L-DOPA—PSIP1—Disease—IL6—malaria	1.48e-05	0.00143	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TLR9—malaria	1.45e-05	0.0014	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TLR9—malaria	1.43e-05	0.00138	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DHODH—malaria	1.39e-05	0.00134	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ACKR1—malaria	1.36e-05	0.00131	CbGpPWpGaD
L-DOPA—DRD1—Circadian rythm related genes—IL6—malaria	1.36e-05	0.00131	CbGpPWpGaD
L-DOPA—DRD3—Circadian rythm related genes—IL6—malaria	1.34e-05	0.00129	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC4A1—malaria	1.19e-05	0.00114	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DECR1—malaria	1.11e-05	0.00108	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TLR9—malaria	1.09e-05	0.00106	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—malaria	1.05e-05	0.00101	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—malaria	1.03e-05	0.000989	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HBB—malaria	1.01e-05	0.000972	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—malaria	9.54e-06	0.00092	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PKLR—malaria	8.98e-06	0.000867	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—KDR—malaria	8.69e-06	0.000838	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—G6PD—malaria	8.01e-06	0.000772	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—malaria	7.75e-06	0.000748	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—malaria	7.04e-06	0.000679	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—malaria	6.98e-06	0.000673	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—malaria	6.88e-06	0.000664	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—KDR—malaria	6.41e-06	0.000619	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—malaria	6.34e-06	0.000611	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—malaria	6.25e-06	0.000603	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—HPGDS—malaria	6.11e-06	0.000589	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—KDR—malaria	5.77e-06	0.000557	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—KDR—malaria	5.7e-06	0.00055	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DHFR—malaria	5.66e-06	0.000547	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—malaria	5.63e-06	0.000543	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SCARB1—malaria	5.61e-06	0.000541	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—malaria	5.6e-06	0.000541	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—malaria	5.27e-06	0.000508	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—malaria	4.78e-06	0.000461	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—KDR—malaria	4.36e-06	0.000421	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—malaria	4.16e-06	0.000401	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—malaria	4.14e-06	0.000399	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—malaria	3.74e-06	0.000361	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—malaria	3.72e-06	0.000359	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—malaria	3.69e-06	0.000356	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—malaria	3.67e-06	0.000354	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CD36—malaria	3.52e-06	0.000339	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—malaria	3.31e-06	0.000319	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—malaria	2.83e-06	0.000273	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—malaria	2.81e-06	0.000271	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—malaria	2.44e-06	0.000236	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—malaria	2.2e-06	0.000212	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—malaria	2.17e-06	0.000209	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—malaria	1.66e-06	0.00016	CbGpPWpGaD
